{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:40Z","timestamp":1793946400133,"version":"4.8.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118741","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:29:30Z","timestamp":1772728170000},"page":"118741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Traditional medicine-derived natural products as anti-osteoporotic Agents: A review on structural modifications, mechanisms, and structure-activity relationships"],"prefix":"10.1016","volume":"309","author":[{"given":"Yinhua","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunquan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118741_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118741_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2026.118741_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.ejmech.2026.118741_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/biom13030483","article-title":"Progress of wnt signaling pathway in osteoporosis","volume":"13","author":"Gao","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118741_bib5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI91086","article-title":"Osteoclast-secreted SLIT3 coordinates bone resorption and formation","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118741_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11657-016-0301-4","article-title":"New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis","volume":"12","author":"He","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ejmech.2026.118741_bib7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118741_bib8","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-Osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.118741_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/M22-0684","article-title":"Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American college of physicians","volume":"176","author":"Ayers","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118741_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/GRF.0000000000000572","article-title":"Bone health and osteoporosis prevention and treatment","volume":"63","author":"Mu\u00f1oz","year":"2020","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ejmech.2026.118741_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000447372","article-title":"Safety of denosumab versus zoledronic acid in patients with bone metastases: a meta-analysis of randomized controlled trials","volume":"39","author":"Chen","year":"2016","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.ejmech.2026.118741_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13697137.2016.1183624","article-title":"Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women","volume":"19","author":"Dinger","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.ejmech.2026.118741_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ejmech.2026.118741_bib16","first-page":"209","article-title":"Observational study of the bisphosphonate-related osteonecrosis of jaws","volume":"91","author":"Lungu","year":"2018","journal-title":"Clujul Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","article-title":"Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery","volume":"189","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1381612822666151112150346","article-title":"Mechanism of treatment of kidney deficiency and osteoporosis is similar by traditional Chinese medicine","volume":"22","author":"Wang","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.118741_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fphar.2019.01344","article-title":"Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis","volume":"10","author":"He","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.apha.2019.07.001","article-title":"Modern traditional Chinese medicine: identifying, defining and usage of TCM components","volume":"87","author":"Newman","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118741_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2026.118741_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.901545","article-title":"Evolving roles of natural terpenoids from traditional Chinese medicine in the treatment of osteoporosis","volume":"13","author":"Zhuo","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.118741_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11418-022-01622-5","article-title":"Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation","volume":"76","author":"El-Desoky","year":"2022","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ptr.2030","article-title":"Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health","volume":"21","author":"Putnam","year":"2007","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2026.118741_bib26","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/np500417d","article-title":"Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-\u03baB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway","volume":"77","author":"Huh","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118741_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ejmech.2026.118741_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ejmech.2026.118741_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyad200","article-title":"Bone morphogenetic protein signaling: the pathway and its regulation","volume":"226","author":"Akiyama","year":"2024","journal-title":"Genetics"},{"key":"10.1016\/j.ejmech.2026.118741_bib30","first-page":"11471","article-title":"The Wnt\/\u03b2-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: an in vivo and in vitro study","volume":"15","author":"Cai","year":"2023","journal-title":"Aging (Albany N. Y.)"},{"key":"10.1016\/j.ejmech.2026.118741_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"TGF-\u03b2 and BMP signaling in osteoblast differentiation and bone formation","volume":"8","author":"Chen","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2026.118741_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.joca.2020.02.027","article-title":"The PI3K\/AKT\/mTOR signaling pathway in osteoarthritis: a narrative review","volume":"28","author":"Sun","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejmech.2026.118741_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biochi.2014.07.003","article-title":"Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells","volume":"105","author":"Park","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2026.118741_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jot.2016.03.001","article-title":"Translational potential of ginsenoside Rb1 in managing progression of osteoarthritis","volume":"6","author":"Chen","year":"2016","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.ejmech.2026.118741_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2006-957705","article-title":"Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera","volume":"63","author":"Mukherjee","year":"1997","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CAD.0b013e3283357c62","article-title":"Betulinic acid, a natural compound with potent anticancer effects","volume":"21","author":"Mullauer","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejmech.2026.118741_bib37","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1021\/jf904158k","article-title":"Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells: involvement of BMP\/Runx2 and beta-catenin signals","volume":"58","author":"Lo","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib38","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1021\/jm201540h","article-title":"Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1021\/acs.jnatprod.5b00709","article-title":"Betulin derivatives effectively suppress inflammation in vitro and in vivo","volume":"79","author":"Laavola","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118741_bib40","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1021\/acs.jmedchem.1c01019","article-title":"Synthesis and biological evaluation of C-17-Amino-Substituted pyrazole-fused betulinic acid derivatives as novel agents for osteoarthritis treatment","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2026.118741_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118741_bib43","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/s41598-019-41140-1","article-title":"The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis","volume":"9","author":"Ashraf","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118741_bib44","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/14740338.2015.1056776","article-title":"Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?","volume":"14","author":"Richette","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2026.118741_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3810\/psm.2011.09.1922","article-title":"The NSAID dilemma: managing osteoarthritis in high-risk patients","volume":"39","author":"Roth","year":"2011","journal-title":"Phys. Sportsmed."},{"key":"10.1016\/j.ejmech.2026.118741_bib46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1055\/s-2005-873147","article-title":"Anti-inflammatory activity of 20(S)-protopanaxadiol: enhanced heme oxygenase 1 expression in RAW 264.7 cells","volume":"71","author":"Lee","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1248\/bpb.b15-00230","article-title":"Anti-fatigue effects of 20(S)-Protopanaxadiol and 20(S)-Protopanaxatriol in mice","volume":"38","author":"Oh","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2026.118741_bib48","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3109\/10717544.2014.997843","article-title":"A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy","volume":"23","author":"Han","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2026.118741_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112710","article-title":"Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuroinflammation in chronic unpredictable mild stress-induced depressive rats","volume":"393","author":"Jiang","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2026.118741_bib50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3389\/fphar.2018.01538","article-title":"20(S)-Protopanaxadiol inhibits titanium particle-induced inflammatory osteolysis and RANKL-mediated osteoclastogenesis via MAPK and NF-\u03baB signaling pathways","volume":"9","author":"Pan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib51","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1021\/jm5002293","article-title":"Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis","volume":"57","author":"Fu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.03.008","article-title":"Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption","volume":"131","author":"Wei","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib53","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1021\/acs.jmedchem.3c00601","article-title":"Synthesis and biological evaluation of Heterocyclic ring-fused 20(S)-Protopanaxadiol derivatives as potent antiosteoporosis agents","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib54","doi-asserted-by":"crossref","first-page":"25229","DOI":"10.1021\/acs.jmedchem.5c02212","article-title":"Synthesis and biological evaluation of heterocycle-fused pyxinol derivatives as anti-osteoporosis agents","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib55","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.drudis.2019.05.017","article-title":"Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents","volume":"24","author":"Soo","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118741_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","article-title":"Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action","volume":"139","author":"Tan","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bph.12463","article-title":"Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"171","author":"Zhai","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib58","doi-asserted-by":"crossref","first-page":"27470","DOI":"10.3390\/ijms161126039","article-title":"Andrographolide inhibits ovariectomy-induced bone loss via the suppression of RANKL signaling pathways","volume":"16","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118741_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113185","article-title":"Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo","volume":"213","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1573406411006040252","article-title":"Synthesis and preliminary anti-HIV activities of andrographolide derivatives","volume":"6","author":"Wang","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543776.2012.661718","article-title":"Modifications of andrographolide to increase some biological activities: a patent review (2006 - 2011)","volume":"22","author":"Aromdee","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118741_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/187220809788700157","article-title":"Microbial biotransformation: recent developments on steroid drugs","volume":"3","author":"Tong","year":"2009","journal-title":"Recent Pat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118741_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","article-title":"Estrogen and bone health in men and women","volume":"99","author":"Cauley","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2026.118741_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/cyto.2001.0962","article-title":"Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells","volume":"16","author":"Gordon","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.ejmech.2026.118741_bib65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bcp.2010.04.014","article-title":"Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice","volume":"80","author":"Lee","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib66","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/acs.jmedchem.4c00349","article-title":"Synthesis of heterocyclic ring-fused bisnoralcohol derivatives as novel small-molecule antiosteoporosis agents","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113106","article-title":"Diverse diterpenoids with \u03b1-glucosidase and \u03b2-glucuronidase inhibitory activities from Euphorbia milii","volume":"196","author":"Yu","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2026.118741_bib68","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1021\/acs.orglett.6b03142","article-title":"Euphomilones A and B, ent-rosane diterpenoids with 7\/5\/6 and 5\/7\/6 skeletons from Euphorbia milii","volume":"18","author":"Liu","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118741_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107253","article-title":"Identification and structural modification of ent-rosane diterpenoids from Euphorbia milii inhibiting RANKL-Induced osteoclastogenesis","volume":"145","author":"Peng","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114249","article-title":"Berberine for bone regeneration: therapeutic potential and molecular mechanisms","volume":"277","author":"Zhang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib71","doi-asserted-by":"crossref","first-page":"e3037","DOI":"10.1038\/cddis.2017.394","article-title":"Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118741_bib72","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1021\/jm300605m","article-title":"New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations","volume":"55","author":"Dong","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib73","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1021\/jm100387d","article-title":"Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents","volume":"53","author":"Dong","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ml500327q","article-title":"Discovery of novel multiacting topoisomerase I\/II and histone deacetylase inhibitors","volume":"6","author":"He","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118741_bib75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jcmm.13955","article-title":"Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice","volume":"23","author":"Jin","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13926","article-title":"An evodiamine derivative inhibits osteoclast differentiation and protects against OVX-induced bone loss in mice","volume":"51","author":"Liu","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejmech.2026.118741_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib78","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/10408347.2022.2105641","article-title":"Bioactive flavonoids: a comprehensive review on pharmacokinetics and analytical aspects","volume":"54","author":"Billowria","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bone.2004.03.031","article-title":"Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice","volume":"35","author":"Fonseca","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2026.118741_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-146-12-200706190-00005","article-title":"Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial","volume":"146","author":"Marini","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib81","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.3390\/molecules25173908","article-title":"Isoliquiritigenin derivatives inhibit RANKL-Induced osteoclastogenesis by regulating p38 and NF-\u03baB activation in RAW 264.7 cells","volume":"25","author":"Jeong","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118741_bib82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2012.11.011","article-title":"The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis","volume":"53","author":"Nelson","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2026.118741_bib83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.118741_bib84","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd3015","article-title":"Late-stage osteoporosis drugs illustrate challenges in the field","volume":"8","author":"Opar","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118741_bib85","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bcp.2013.03.002","article-title":"Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies","volume":"85","author":"Esbrit","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10540-005-2896-3","article-title":"Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion","volume":"25","author":"Adayev","year":"2005","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2026.118741_bib87","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neubiorev.2013.04.009","article-title":"Systematic review, structural analysis, and new theoretical perspectives on the role of serotonin and associated genes in the etiology of psychopathy and sociopathy","volume":"37","author":"Yildirim","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2026.118741_bib88","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function","volume":"100","author":"C\u00f4t\u00e9","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118741_bib89","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.biopsych.2003.09.002","article-title":"Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland","volume":"55","author":"Patel","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.118741_bib90","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118741_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.107.132670","article-title":"Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract","volume":"325","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2026.118741_bib93","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1016\/j.bmc.2005.06.004","article-title":"Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives","volume":"13","author":"Wang","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib94","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.ejmech.2009.02.025","article-title":"Synthesis and anti-osteoporotic evaluation of certain 3-amino-2-hydroxypropoxyisoflavone derivatives","volume":"44","author":"Tseng","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib95","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1021\/jm0101287","article-title":"Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity","volume":"44","author":"Habeeb","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib96","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm049802l","article-title":"Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents","volume":"47","author":"Liou","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib97","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/jm061142s","article-title":"Highly potent triazole-based tubulin polymerization inhibitors","volume":"50","author":"Zhang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib98","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/jm061035y","article-title":"Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains","volume":"50","author":"Zhou","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib99","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.bmcl.2004.08.046","article-title":"Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core","volume":"14","author":"Compton","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118741_bib100","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1021\/jm049631k","article-title":"Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity","volume":"47","author":"Compton","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib101","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.bmc.2010.05.062","article-title":"Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives","volume":"18","author":"Tseng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib102","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.bmc.2007.12.028","article-title":"Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives","volume":"16","author":"Tseng","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib103","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/jm200046z","article-title":"Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers","volume":"54","author":"Chen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib104","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2174\/1573406411309050015","article-title":"Synthesis of aminoalkoxy substituted 4,5-diphenylisoxazole derivatives as potential anti-osteoporotic agents","volume":"9","author":"Chen","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0306-3623(95)02112-4","article-title":"Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential","volume":"27","author":"Hoult","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib106","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/np50032a011","article-title":"Plant anticancer agents XXIX. Cleomiscosin A from Simaba multiflora, Soulamea soulameoides, and Matayba arborescens","volume":"47","author":"Arisawa","year":"1984","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.118741_bib107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2007.10.013","article-title":"Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts","volume":"579","author":"Tang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118741_bib108","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3892\/or.2016.4586","article-title":"Imperatorin exhibits anticancer activities in human colon cancer cells via the caspase cascade","volume":"35","author":"Zheng","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2026.118741_bib109","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-015-0403-4","article-title":"Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells","volume":"14","author":"De Amicis","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118741_bib110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12032-007-9019-x","article-title":"Aromatase inhibitors: past, present and future in breast cancer therapy","volume":"25","author":"Dutta","year":"2008","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.118741_bib111","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ejmech.2013.10.060","article-title":"Synthesis and evaluation of new coumarin-pyridine hybrids with promising anti-osteoporotic activities","volume":"70","author":"Sashidhara","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib112","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1021\/jm9018756","article-title":"Emerging targets in osteoporosis disease modification","volume":"53","author":"Allen","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib113","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1258\/ebm.2011.011296","article-title":"Effect of catch-up growth by various dietary patterns and resveratrol intervention on bone status","volume":"237","author":"Chen","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ejmech.2026.118741_bib114","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1139\/h2012-099","article-title":"Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature Fisher 344 \u00d7 brown Norway male rats","volume":"37","author":"Durbin","year":"2012","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.ejmech.2026.118741_bib115","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1210\/endo.141.10.7721","article-title":"Resveratrol acts as a mixed agonist\/antagonist for estrogen receptors alpha and beta","volume":"141","author":"Bowers","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2026.118741_bib116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejmech.2015.07.042","article-title":"Synthesis, estrogenic activity, and anti-osteoporosis effects in ovariectomized rats of resveratrol oligomer derivatives","volume":"102","author":"Hao","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib117","doi-asserted-by":"crossref","first-page":"15738","DOI":"10.1021\/acs.jmedchem.4c01377","article-title":"Discovery of novel neo-clerodane derivatives as potent dual-functional antiosteoporosis agents through targeting Peroxisome proliferator-activated Receptor-\u03b3","volume":"67","author":"Peng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib118","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0002-9378(89)80004-3","article-title":"Estrogens in the prevention of osteoporosis in postmenopausal women","volume":"161","author":"Genant","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejmech.2026.118741_bib119","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1359\/jbmr.2002.17.10.1904","article-title":"Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study","volume":"17","author":"Morabito","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2026.118741_bib120","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.142.8.8310","article-title":"Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis","volume":"142","author":"Yamagishi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2026.118741_bib121","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1359\/jbmr.2002.17.4.630","article-title":"Down-regulation of osteoclast differentiation by daidzein via caspase 3","volume":"17","author":"Rassi","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2026.118741_bib122","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2004-827147","article-title":"Anti-inflammatory isoflavonoids from the stems of Derris scandens","volume":"70","author":"Laupattarakasem","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.118741_bib123","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/med.10033","article-title":"Flavonoids: promising anticancer agents","volume":"23","author":"Ren","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.118741_bib124","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1522-2675(20010815)84:8<2417::AID-HLCA2417>3.0.CO;2-N","article-title":"Novel basic isoflavones as inhibitors of bone resorption","volume":"84","author":"Delcanale","year":"2001","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2026.118741_bib125","doi-asserted-by":"crossref","first-page":"80037","DOI":"10.1039\/C6RA15674F","article-title":"Design, synthesis and in vitro evaluation of coumarin\u2013imidazo [1, 2-a] pyridine derivatives against cancer induced osteoporosis","volume":"6","author":"Sashidhara","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118741_bib126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bone.2016.03.016","article-title":"Estrogen receptors alpha and beta in bone","volume":"87","author":"Khalid","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2026.118741_bib127","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13697137.2021.1936485","article-title":"Selective estrogen receptor modulators and bone health","volume":"25","author":"Goldstein","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.ejmech.2026.118741_bib128","article-title":"Bone-turnover biomarkers as potential prognostic factors in sudden sensorineural hearing loss: a prospective cohort study","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejmech.2026.118741_bib129","doi-asserted-by":"crossref","first-page":"22715","DOI":"10.1021\/acs.jmedchem.5c01697","article-title":"Discovery of novel selective Estrogen receptor \u03b2 (SER\u03b2) agonist (S)-STO021 as an antiosteoporosis candidate with dual functions of inhibiting osteoclastogenesis and activating osteoblastogenesis","volume":"68","author":"Peng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118741_bib130","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1021\/mp200209j","article-title":"Cocrystals of quercetin with improved solubility and oral bioavailability","volume":"8","author":"Smith","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.118741_bib131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2019.02.027","article-title":"Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine","volume":"561","author":"Wang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2026.118741_bib132","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/21691401.2017.1375938","article-title":"Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability","volume":"46","author":"Zuo","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:13:41Z","timestamp":1784668421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":132,"alternative-id":["S0223523426001868"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118741","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional medicine-derived natural products as anti-osteoporotic Agents: A review on structural modifications, mechanisms, and structure-activity relationships","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118741"}}